ANAB: Phase 1 Data Readout (Partnership)
Resolves: Positive interim results from the first Phase 1 clinical trial initiated under the partnership.
sec_filing· Clinical Trial Progress
ANAB: Phase 1 Data Readout (Partnership)
Market overview
Derived from ANAPTYSBIO, INC (ANAB) (CIK 0001370053) 8-K filing analysis
Clinical Trial Progress prediction market
- Implied probability (Yes)
- 55%
- Closes
- 2028-03-21
About this prediction
Resolution criteria
Positive interim results from the first Phase 1 clinical trial initiated under the partnership.
More Clinical Trial Progress markets
No one's made a Conviction call on this yet. Be the first to call it →
Loading…